Thoughtful Story on the Cells=Drugs Controversy

cells=drugs controversy

Orthopedics this Week and Walter Eisner did a great job exploring the pros and cons of the FDA considering our Regenexx-C procedure a drug (which forced us to move that procedure to the Cayman Islands). It’s a balanced read on the cells=drugs controversy, here’s the link to the full story “Stem Cell Therapies: Clinical Practice or a Drug?” Here’s the link to the story at the OTW site. 

Learn More About Regenexx® Procedures
Request a digital booklet and more information to learn about alternatives to orthopedic surgery and the Regenexx patient experience.
We do not sell, or share your information to third party vendors. By submitting the form you agree that you've read and consent to our Privacy Policy.
Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

TO TOP